ClinicalTrials.gov
public full text
Public Domain
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ketamine Infusion for Sickle Cell Pain Crisis#830974
- Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome.#897481
- Comparison the Effects of 3 Different Intraarticular Ketamine Doses on Postoperative Pain.#1197499
- Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty#1128166
- Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis#1323171
Record · ID 1182845
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive